Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210036898 210012844 null 47 Curative (C) 2014-01-17 2018-08-15 Cytarabine intrathecal N null 210037617 CYTARABINE HD + METHOTREXATE HD
210036899 210038650 0 61.7 Curative (C) 2015-10-22 2015-10-31 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE 02 null 210037781 CAPECITABINE
210036900 210012882 1.72 null Palliative (P) null 2017-08-20 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210037785 IRINOTECAN + MDG
210036901 210012890 null 68.6 Curative (C) 2018-06-08 2018-06-14 Phase 2 Induction (ALL) Y null 210037803 PACKER MAINTENANCE
210036902 210022152 1.65 54 Curative (C) 2015-05-28 2018-10-02 Cytarabine intrathecal N N 210038157 TAMIGA TRIAL
210036903 210022154 1.21 50 null 2015-07-19 2015-07-19 BEAM 99 N 210038174 TAMIGA TRIAL
210036904 210022157 0 66.7 Palliative (P) null 2020-02-01 CNS LGG Irinotecan & Bevacizumab N null 210038187 DOXORUBICIN
210036905 210012985 1.52 null Curative (C) 2012-07-17 2016-12-12 Cytarabine intrathecal N N 210038312 CISPLATIN + ETOPOSIDE
210036906 210027920 null 76.7 Disease modification (D) 2017-06-19 2017-06-19 Cytarabine intrathecal Y N 210038363 OFATUMUMAB
210036907 210013026 1.79 null Curative (C) 2018-07-26 2018-07-26 CVP 01 N 210038500 TAMIGA TRIAL
210036908 210013068 1.72 68 Curative (C) 2017-11-30 2018-05-19 TAMIGA trial N N 210038669 OLAPARIB
210036909 210013109 1.63 74.2 Palliative (P) 2018-10-19 2018-10-20 PEMBROLIZUMAB N N 210038851 BEVACIZUMAB + LOMUSTINE
210036910 210013145 0 null Curative (C) 2020-01-15 2020-01-15 TAMIGA trial N N 210039036 DOCETAXEL
210036911 210027977 1.65 76.399 Curative (C) 2015-03-16 2015-03-16 CYCLET N N 210039212 PACKER MAINTENANCE
210036912 210013212 null 69.8 Disease modification (D) 2016-02-19 2016-02-19 CAV 2 N 210039328 BR14 TRIAL
210036913 210022306 1.55 68.8 Curative (C) 2016-07-17 2016-07-21 Fludarabine IV null null 210039434 FEC
210036914 210013260 1.67 54 Palliative (P) null 2016-07-30 CISPLATIN + VINCRISTINE Y N 210039601 ERIBULIN
210036915 210013271 1.72 108.4 Curative (C) 2019-03-05 2019-04-09 CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE N N 210039685 ERLOTINIB
210036916 210013287 0 0 Palliative (P) 2015-05-12 2015-05-13 CYTARABINE N N 210039746 NILOTINIB
210036917 210013316 null 68.6 Curative (C) null 2017-04-01 FLAG N null 210039899 CYCLOPHOSPHAMIDE HIGH DOSE
210036918 210031493 null 91.2 Curative (C) 2017-12-17 2017-12-18 CNS LGG Irinotecan & Bevacizumab 02 null 210040628 PENTOSTATIN + RITUXIMAB
210036919 210013483 0 54.4 Curative (C) 2018-07-16 2018-07-16 CLOFARABINE + CYCLO + CYTARABINE + ETOP 2 N 210040958 VAI
210036920 210013493 1.62 56.3 Curative (C) 2015-04-06 2015-08-11 Depocyte Intrathecal Y N 210041021 BRENTUXIMAB
210036921 210028093 null 12.2 null 2016-01-29 2016-11-17 BCG Intravesical 2 null 210041357 VINORELBINE
210036922 210013623 1.74 75.8 Palliative (P) 2020-04-28 2020-04-28 CNS Medbl Std Risk Maint Cisplatin 02 N 210041817 CYCLO + FLUDARABINE + RITUXIMAB
210036923 210022531 0 98 Palliative (P) 2018-06-18 2018-06-18 BR14 TRIAL null null 210042069 CLARITY TRIAL
210036924 210013674 null 11.8 Curative (C) null 2018-12-05 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N null 210000284 ALL
210036925 210028184 1.65 68.6 Curative (C) 2011-09-26 2018-06-03 CARBOPLATIN + LOMUSTINE + VINCRISTINE N N 210028705 CYCLOPHOSPHAMIDE HIGH DOSE
210036926 210035167 1.82 76 Curative (C) null 2016-07-23 FCR IV - Cycle 2 onwards N N 210029666 CYCLO + FLUDARABINE + RITUXIMAB
210036927 210013814 1.72 null Curative (C) 2019-07-05 2019-07-19 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE Y null 210030225 ICE-R
210036928 210013842 1.56 93 Curative (C) 2017-03-12 2017-11-20 Bevacizumab + Temozolomide N null 210031205 BORTEZOMIB
210036929 210013883 1.79 null Curative (C) 2016-12-27 2017-12-26 MITOMYCIN N N 210033322 IDARUBICIN
210036930 210013931 0 74.7 null null 2018-11-12 THALIDOMIDE N N 210035201 FLUDARABINE
210036931 210013953 1.85 68.2 Curative (C) 2018-09-29 2018-10-10 Cytarabine intrathecal Y N 210036454 OXALIPLATIN + MDG
210036932 210014051 1.67 null Disease modification (D) null 2019-09-29 ABVD N N 210041781 CYCLO + FLUDARABINE + RITUXIMAB
210036933 210022771 1.81 55.6 Disease modification (D) 2019-04-16 2019-04-20 Abiraterone N N 210034307 ALL MAINTENANCE
210036935 210004377 1.84 85 Adjuvant (A) 2018-10-15 2018-10-23 Temozolomide 200mg/m2 2 N 210000395 TEMOZOLOMIDE
210036936 210004406 1.71 59.8 Palliative (P) 2016-10-07 2017-01-14 Temozolomide 200mg/m2 N N 210000602 TEMOZOLOMIDE
210036937 210038311 1.71 132 Palliative (P) 2017-03-18 2017-03-18 TEMOZOLOMIDE 02 null 210000612 TEMOZOLOMIDE
210036938 210032436 1.69 null Adjuvant (A) 2017-03-28 2017-03-28 TEMOZOLOMIDE N N 210000818 TEMOZOLOMIDE
210036939 210004511 1.83 null Curative (C) 2019-10-12 2020-01-19 Temozolomide 150mg/m2 N N 210001305 TEMOZOLOMIDE
210036940 210004531 1.75 null Adjuvant (A) 2014-06-26 2014-11-05 Temozolomide 200mg/m2 2 null 210001469 TEMOZOLOMIDE
210036941 210017348 1.78 88.4 Adjuvant (A) 2016-11-13 2016-11-20 Temozolomide 200mg/m2 N N 210001686 TEMOZOLOMIDE
210036944 210017381 1.66 63 Not known (9) 2014-04-08 2014-07-09 Temozolomide 200mg/m2 N N 210002085 TEMOZOLOMIDE
210036945 210029539 0 64.5 Curative (C) 2019-09-03 2019-09-07 TEMOZOLOMIDE 02 null 210002644 TEMOZOLOMIDE
210036946 210004761 1.82 66.65 Curative (C) null 2015-07-24 TEMOZOLOMIDE null null 210002776 TEMOZOLOMIDE
210036947 210004798 1.72 76.5 null 2012-07-05 2015-01-19 Temozolomide 200mg/m2 N N 210002975 TEMOZOLOMIDE
210036948 210017477 0 49 Curative (C) 2017-05-04 2018-04-11 ALL UKALL2011 Maintenance A1 Y N 210003399 UKALL2011
210036949 210017493 null 14.45 Curative (C) 2018-08-02 2018-08-23 ALL UKALL2011 Std BFM Cons B Y null 210003544 UKALL2011
210036950 210004895 0.96 21.2 Curative (C) 2015-07-25 2015-08-07 ALL UKALL2011 Maintenance A1 01 null 210003552 UKALL2011